Obidoxime (Cl)

Obidoxime (Cl) is a cholinesterase reactivator with similar actions and uses pralidoxime. Obidoxime (Cl) is given in combination with atropine in the treatment of organophosphorous poisoning.

Brands
Adult Dose
Neonatal
Paedriatic
Dose:
Single Dose:
Frequency:
Route:
Instructions:
Characteristics
. It is of Synthetic origin. . The Molecular Weight of Obidoxime (Cl) is 359.20. Its pKa is 7.7.
Contraindications
Obidoxime (Cl) is contraindicated in conditions like Hypersensitivity.
Effects
The severe or irreversible adverse effects of Obidoxime (Cl), which give rise to further complications include Mania, Excitement, Non-oliguric renal failure, Transient liver damage.Obidoxime (Cl) produces potentially life-threatening effects which include Cardiac arrhythmia, QT prolongation. which are responsible for the discontinuation of Obidoxime (Cl) therapy.The symptomatic adverse reactions produced by Obidoxime (Cl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Tachycardia, Dry mouth, Transient hypotension, Hot feeling in facial area, Dry mouth, Tachycardia, feeling of coldness in nasopharynx.
Indications
Obidoxime (Cl) is primarily indicated in conditions like Acute poisoning with organophosphorus ester.
Interactions
No data regarding the interactions of Obidoxime (Cl) was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
IV Inj, IM Inj
Warnings
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.